These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16716113)

  • 1. Chimeric adeno-associated virus/antisense U1 small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice.
    Denti MA; Rosa A; D'Antona G; Sthandier O; De Angelis FG; Nicoletti C; Allocca M; Pansarasa O; Parente V; Musarò A; Auricchio A; Bottinelli R; Bozzoni I
    Hum Gene Ther; 2006 May; 17(5):565-74. PubMed ID: 16716113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.
    Vulin A; Barthélémy I; Goyenvalle A; Thibaud JL; Beley C; Griffith G; Benchaouir R; le Hir M; Unterfinger Y; Lorain S; Dreyfus P; Voit T; Carlier P; Blot S; Garcia L
    Mol Ther; 2012 Nov; 20(11):2120-33. PubMed ID: 22968479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering exon-skipping vectors expressing U7 snRNA constructs for Duchenne muscular dystrophy gene therapy.
    Goyenvalle A; Davies KE
    Methods Mol Biol; 2011; 709():179-96. PubMed ID: 21194028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
    Goyenvalle A; Vulin A; Fougerousse F; Leturcq F; Kaplan JC; Garcia L; Danos O
    Science; 2004 Dec; 306(5702):1796-9. PubMed ID: 15528407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy.
    Le Hir M; Goyenvalle A; Peccate C; Précigout G; Davies KE; Voit T; Garcia L; Lorain S
    Mol Ther; 2013 Aug; 21(8):1551-8. PubMed ID: 23752313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model.
    Denti MA; Rosa A; D'Antona G; Sthandier O; De Angelis FG; Nicoletti C; Allocca M; Pansarasa O; Parente V; Musarò A; Auricchio A; Bottinelli R; Bozzoni I
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3758-63. PubMed ID: 16501048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin Type IIB receptor in mdx mice.
    Hoogaars WM; Mouisel E; Pasternack A; Hulmi JJ; Relizani K; Schuelke M; Schirwis E; Garcia L; Ritvos O; Ferry A; 't Hoen PA; Amthor H
    Hum Gene Ther; 2012 Dec; 23(12):1269-79. PubMed ID: 22894762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy.
    Goyenvalle A; Babbs A; van Ommen GJ; Garcia L; Davies KE
    Mol Ther; 2009 Jul; 17(7):1234-40. PubMed ID: 19455105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U7 snRNAs induce correction of mutated dystrophin pre-mRNA by exon skipping.
    Brun C; Suter D; Pauli C; Dunant P; Lochmüller H; Burgunder JM; Schümperli D; Weis J
    Cell Mol Life Sci; 2003 Mar; 60(3):557-66. PubMed ID: 12737315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice.
    Denti MA; Incitti T; Sthandier O; Nicoletti C; De Angelis FG; Rizzuto E; Auricchio A; Musarò A; Bozzoni I
    Hum Gene Ther; 2008 Jun; 19(6):601-8. PubMed ID: 18500943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy.
    Kendall GC; Mokhonova EI; Moran M; Sejbuk NE; Wang DW; Silva O; Wang RT; Martinez L; Lu QL; Damoiseaux R; Spencer MJ; Nelson SF; Miceli MC
    Sci Transl Med; 2012 Dec; 4(164):164ra160. PubMed ID: 23241744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
    Goyenvalle A; Babbs A; Wright J; Wilkins V; Powell D; Garcia L; Davies KE
    Hum Mol Genet; 2012 Jun; 21(11):2559-71. PubMed ID: 22388933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
    Koo T; Malerba A; Athanasopoulos T; Trollet C; Boldrin L; Ferry A; Popplewell L; Foster H; Foster K; Dickson G
    Hum Gene Ther; 2011 Nov; 22(11):1379-88. PubMed ID: 21453126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
    Barbash IM; Cecchini S; Faranesh AZ; Virag T; Li L; Yang Y; Hoyt RF; Kornegay JN; Bogan JR; Garcia L; Lederman RJ; Kotin RM
    Gene Ther; 2013 Mar; 20(3):274-82. PubMed ID: 22551778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH; Sirsi SR; Latta DR; Lutz GJ
    Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon skipping and duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping.
    Incitti T; De Angelis FG; Cazzella V; Sthandier O; Pinnarò C; Legnini I; Bozzoni I
    Mol Ther; 2010 Sep; 18(9):1675-82. PubMed ID: 20551908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle.
    Takeshima Y; Yagi M; Wada H; Matsuo M
    Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
    Koo T; Popplewell L; Athanasopoulos T; Dickson G
    Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles.
    Peccate C; Mollard A; Le Hir M; Julien L; McClorey G; Jarmin S; Le Heron A; Dickson G; Benkhelifa-Ziyyat S; Piétri-Rouxel F; Wood MJ; Voit T; Lorain S
    Hum Mol Genet; 2016 Aug; 25(16):3555-3563. PubMed ID: 27378686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for antisense modulation of dystrophin pre-mRNA splicing.
    Dickson G; Hill V; Graham IR
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S67-70. PubMed ID: 12206799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.